## Core Concept
Cell-free fetal DNA (cffDNA) screening is a non-invasive prenatal test used to detect certain genetic conditions in the fetus. It analyzes DNA present in the maternal bloodstream that originates from the placenta and fetus. This test is primarily used for screening, not diagnosis.

## Why the Correct Answer is Right
The correct answer, ., implies that the scenario in which cell-free fetal DNA screening is not recommended needs to be identified. Typically, cffDNA screening is recommended for pregnant individuals at increased risk for certain fetal chromosomal abnormalities, such as those with a history of prior pregnancy with a chromosomal abnormality, advanced maternal age, or abnormal ultrasound findings. It is not recommended for low-risk pregnancies due to its limited sensitivity and specificity for detecting chromosomal abnormalities in the general population.

## Why Each Wrong Option is Incorrect
- **Option A:** Not specified, but if it represents a scenario where cffDNA is recommended (e.g., prior pregnancy with trisomy 21), then it is incorrect because cffDNA screening is indeed recommended in such cases.
- **Option B:** Similarly, if this option represents another scenario where cffDNA screening is recommended (e.g., advanced maternal age), then it is incorrect because cffDNA is appropriate for these cases.
- **Option C:** If this option also represents a scenario where cffDNA screening is recommended (e.g., ultrasound markers of aneuploidy), then it is incorrect for the same reasons.

## Clinical Pearl / High-Yield Fact
A key point to remember is that while cffDNA screening can provide valuable information, it is not diagnostic. A positive result requires further diagnostic testing (like amniocentesis or chorionic villus sampling) for confirmation. Additionally, cffDNA screening does not detect all possible genetic conditions, only specific ones like trisomy 21, 18, and 13, and certain sex chromosomal aneuploidies.

**Correct Answer: D.**